Protecting Texas Medicaid Program from Unlawful Federal Changes

Translate to Spanish or other 102 languages!

The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Image for illustration purposes
The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Image for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN – Texas Attorney General Paxton has launched a legal battle against the Centers for Medicare and Medicaid Services (CMS) and the U.S. Department of Health and Human Services (HHS), contesting a federal bulletin that poses a threat to Texas’s Medicaid program and its nearly five million beneficiaries. 

The lawsuit argues that the imposed requirements are neither supported by existing laws nor mandated by current regulations. Furthermore, Attorney General Paxton has filed a motion for a preliminary injunction to halt CMS’s actions.

Attorney General Paxton expressed concerns that CMS’s actions could jeopardize not only local governments’ ability to support Medicaid providers but also the entire state’s capacity to fund its Medicaid program. The potential consequences of CMS’s actions could lead to reduced access to healthcare for vulnerable Texans and hinder local providers’ ability to serve communities across the state.

- Advertisement -

Texas’s Medicaid program relies on funding from both the state and federal government, with local governments also contributing to ensure access to healthcare for citizens, irrespective of income level. Since 2013, and with CMS’s authorization, Texas has permitted local governments to administer Local Provider Participation Funds (LPPFs). In 2021, the Biden administration’s CMS attempted to revoke Texas Medicaid’s use of LPPFs, but a preliminary injunction was issued against this effort.

LPPFs involve local governments collecting mandatory assessments from healthcare providers and transferring these funds to the state to finance Texas’s share of non-federal Medicaid funding. Federal law explicitly allows such arrangements. However, federal law also prohibits hold harmless arrangements, which guarantee healthcare providers will receive their total tax payment back through Medicaid payments. CMS recently issued an unlawful informational bulletin that would wrongly classify private contracts involving entities that contribute to an LPPF as prohibited hold harmless arrangements, even though federal law does not prohibit such private contracts.

CMS’s bulletin revealed its intent to require the Texas Health and Human Services Commission (HHSC) to provide information about these private “hold harmless arrangements” as a prerequisite for receiving federal funding, despite the HHSC’s lack of authority to do so. This could potentially endanger billions of dollars meant for Texas’s Medicaid program. The changes represent a significant departure from CMS’s previous policy and an unprecedented expansion of its authority.

To read the full complaint, click here.  

- Advertisement -

To read the motion for preliminary injunction, click here

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Reveals Link Between Parent and Child Weight Is Mostly Genetic

The link between parents’ body mass index (BMI) and their children’s BMI in childhood is driven largely by genetic inheritance, rather than by any direct biological effects of parental weight during pregnancy, a new study suggests.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

The Genetic Armor Defeating Colorectal Cancer

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University, and institutions across the U.S., have published a landmark paper on the role of TGFBR1*6A, a naturally occurring genetic mutation in the TGFBR1 gene found in approximately 14 percent of the general population. Image for illustration purposes

Why CKM Syndrome Requires a Coordinated Care Point Person

When the term “cardiovascular-kidney-metabolic syndrome” was created in 2023 to define how heart disease, kidney disease, obesity and diabetes are connected, one goal was to help health professionals understand the benefits of working together.
- Advertisement -